JPMORGAN CHASE & CO - AQUINOX PHARMACEUTICALS INC ownership

AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 35 filers reported holding AQUINOX PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of AQUINOX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$114,000
-69.4%
47,807
-65.4%
0.00%
Q1 2019$372,000
-11.8%
138,212
-29.3%
0.00%
Q4 2018$422,000
-48.7%
195,353
-30.5%
0.00%
Q3 2018$823,000
+2124.3%
280,894
+10649.9%
0.00%
Q1 2018$37,000
-83.8%
2,613
-86.5%
0.00%
Q4 2017$228,000
+1420.0%
19,356
+1041.9%
0.00%
Q1 2016$15,0001,6950.00%
Other shareholders
AQUINOX PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Boxer Capital, LLC 877,753$14,492,0005.61%
RA Capital Management 2,191,977$36,190,0005.13%
Opaleye Management Inc. 310,000$5,118,0003.02%
EMORY UNIVERSITY 143,691$2,372,0002.34%
Baker Brothers Advisors 10,536,092$173,951,0001.70%
Ghost Tree Capital, LLC 225,000$3,715,0000.89%
Cormorant Asset Management, LP 151,838$2,507,0000.34%
Eventide Asset Management 175,000$2,889,0000.19%
JGP Global Gestao de Recursos Ltda. 11,380$188,0000.10%
Virtus ETF Advisers LLC 16,347$270,0000.08%
View complete list of AQUINOX PHARMACEUTICALS INC shareholders